Lindora is a medical weight-loss and metabolic health clinic franchise from Southern California. Its clinics sell physician-supervised GLP-1 weight-loss programs, hormone and testosterone replacement therapy, IV hydration, Zerona non-invasive body contouring, and supplements. That menu overlaps heavily with the clinic side of Optimize U, and almost entirely with Medi-Weightloss.

The brand has changed hands twice in the period this review covers. Xponential Fitness owned it when the 2024 FDD was written. In September 2025, Xponential sold it to Next Health, which reopened Lindora franchise sales on February 1, 2026 and has since named the nutrition author JJ Virgin as Chief Metabolic Health Officer to lead new programming. Figures below come from the 2024 FDD. Get the current one before modeling anything. We are not affiliated with, endorsed by, or compensated by Lindora or Next Health. See our disclosure policy.

What it costs (2024 FDD)

Total initial investment

$272,350–$491,750

Initial franchise fee

$60,000

Royalty

7% of gross sales

Brand fund

2% of gross sales

Local advertising

Local spend and cooperative contributions, as required

At a $382,050 midpoint, Lindora sits in the same capital range as Medi-Weightloss ($374,305) and Optimize U's 2022 figures ($420,750). It is a clinic build: treatment and consultation rooms, a lab draw area and an IV area, rather than a floor of recovery equipment.

The Item 19, and whose clinics it describes

Lindora's 2024 Item 19 is one of the more detailed in the medical category. It reports, month by month from March 2023 to February 2024, the average, median and range of gross revenue for 22 "Qualified Clinics": clinics operated by a franchisee for the whole period, excluding eight clinics inside medical offices and one at a non-traditional site.

March 2023

Average
$71,268
Median
$69,960

June 2023

Average
$89,223
Median
$84,444

September 2023

Average
$84,722
Median
$77,867

December 2023

Average
$82,040
Median
$75,190

February 2024

Average
$92,702
Median
$88,366

Across all twelve months the average rose from $71,268 to $92,702, and individual clinics ranged from $28,799 to $148,933 in a month. Because the same 22 clinics are in every month, adding the twelve monthly averages gives an annual average of about $1,023,705, which is 2.68 times the investment midpoint. That is our arithmetic, not a figure the FDD states.

Now the caveat that matters. Item 20 shows Lindora going from zero to 31 franchised clinics in 2023, and its footnote explains why: as of December 1, 2023, the franchisor's predecessor owned and operated all 31 clinics as its franchisee. The franchise system was created around an existing chain. So the "franchised" clinics in Item 19 were run by the brand's own long-time operator, not by independent buyers who paid a fee and opened a new clinic. Read the figures as a picture of a mature, company-run clinic network. That is why our comparison table leaves Lindora's revenue blank, as it does for other brands whose Item 19 covers only affiliate locations.

Cost of goods, by service line

The 2024 FDD also discloses cost of goods as a share of each line's revenue, which few brands do:

HRT/TRT and GLP-1

Clinics offering it
20
Average COGS
19%
Range
16%–24%

IV hydration

Clinics offering it
10
Average COGS
24%
Range
18%–30%

Supplements and products

Clinics offering it
22
Average COGS
49%
Range
44%–52%

Zerona body contouring

Clinics offering it
15
Average COGS
14%
Range
9%–22%

The spread is the useful part. Prescription programs and Zerona carry thin product costs; supplements carry about half their price in cost. A clinic whose revenue tilts toward retail will keep far less per dollar of sales than one built on GLP-1 and hormone programs, though the royalty is the same 9% on both.

Fees against gross margin

Seven percent plus two is 9% of sales, below Medi-Weightloss's 10% plus 1% and level with Optimize U's 9% royalty. On the HRT/TRT and GLP-1 line, at 19% cost of goods, a 9% fee equals about 11.1% of gross margin. On supplements, at 49%, it equals about 17.6%. Model your own mix with the royalty calculator rather than the headline rate.

GLP-1 economics also deserve a separate look. The measurement period ended in February 2024, when compounded semaglutide was widely available. Since then the FDA has removed semaglutide and tirzepatide from its shortage list, which narrows how compounding pharmacies can supply them. Ask how current clinics source medication, and what has happened to program pricing and margins since.

Medicine and ownership

GLP-1 drugs and testosterone are prescription medications, and testosterone is a controlled substance, so every clinic needs licensed providers and must follow state rules on prescribing and on who may own a medical practice. Where a state restricts ownership, expect a management structure between your company and a provider-owned practice. Ask Lindora how it arranges medical directors and providers in your state, and how the royalty is defined under that structure.

Who this fits

Lindora suits a buyer who wants a medical weight-loss and hormone clinic with a long operating history behind it, and who values detailed cost disclosure. The brand now sits inside Next Health, which brings a larger longevity platform and new programming, and also new management and a franchise system restarting under a new owner.

It fits poorly for anyone who needs evidence from independent franchisees, since the 2024 Item 19 has none, and for anyone uneasy about how much GLP-1 demand and pricing could shift.

Before you sign

Get the 2026 FDD and compare it with the figures here: investment, fees, and especially whether the new Item 19 includes clinics opened by independent franchisees. Ask how many of the original 31 clinics are still operated by the predecessor company, and call the franchisees listed in Item 20. Have a healthcare attorney confirm the ownership structure in your state. Then compare Lindora head to head with Optimize U and Medi-Weightloss, and see our medical wellness cost comparison. For the clinic's back office, our clinical operations directory compares EHRs, lab accounts, medical supply distributors and hormone therapy programs.

Sources

Frequently asked questions

How much does a Lindora franchise cost?
The 2024 FDD, the latest reviewed here, disclosed a total initial investment of $272,350 to $491,750, including a $60,000 initial franchise fee. Next Health reopened franchise sales in February 2026 after buying the brand, so confirm the current Item 7.
How much does a Lindora clinic make?
The 2024 FDD reported monthly revenue for 22 clinics open for the full year from March 2023 to February 2024. Adding the twelve monthly averages gives about $1,023,705 a year. Every one of those clinics was operated by the franchisor's predecessor company, so they show what the brand's own operator achieved, not independent franchisees.
What are Lindora's ongoing fees?
The 2024 FDD set a royalty of 7% and a brand fund of 2%, 9% of sales in total, with local advertising and any cooperative contributions on top. On $1 million of revenue that is $90,000 a year before local marketing.
Who owns Lindora?
Next Health, the longevity clinic franchisor, bought Lindora from Xponential Fitness in September 2025. Next Health said it would keep Lindora as its own brand, and Lindora's franchise sales relaunched on February 1, 2026.

Related guides

Get an alert when Lindora's numbers change

Franchisors refile their FDD every year, and the figures move. We'll email you when this review is updated with Lindora's new disclosure, plus occasional buyer-side insights. No spam.

Prefer downloads? Browse free resources.